CIAM
PYXS icon

Caitong International Asset Management’s Pyxis Oncology PYXS Stock Holding History

Caitong International Asset Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Buy
+4
New +$6 ﹤0.01% 2244
2025
Q3 		– Sell
-1
Closed -$1 – 2400
2025
Q2 		$1 Sell
1
-2
-67% -$2 ﹤0.01% 1933
2025
Q1 		$3 Sell
3
-324
-99% -$432 ﹤0.01% 2101
2024
Q4 		$510 Buy
+327
New +$943 ﹤0.01% 1460

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caitong International Asset Management's PYXS Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Pyxis Oncology (PYXS) in Q1 2026: 4 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #2244 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in PYXS as recently as Q2 2025.

Caitong International Asset Management first reported a position in PYXS in Q4 2024 and has held it in 4 quarters since. The position peaked at $510 in Q4 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Caitong International Asset Management held 4 shares of Pyxis Oncology worth $6 as of Q1 2026.
  • Pyxis Oncology was a new Caitong International Asset Management position in Q1 2026.
  • Pyxis Oncology made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2244 holding.
  • Caitong International Asset Management first reported a position in Pyxis Oncology in Q4 2024 and has held it in 4 quarters since.
  • Caitong International Asset Management's Pyxis Oncology position peaked at $510 in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.